These limitations and challenges can be classified into six primary categories: (1) the development of new catalysts; (2) environmental and safety concerns; (3) reactivity and selectivity issues; (4) ...

JUPITER, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and twelve months ended December 31, 2024 ...

JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a loss of $31.1 million in its fourth quarter. On a per-share basis, the Jupiter, Florida ...

(RTTNews) - Biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND), while reporting a loss in its fourth quarter, compared to prior year's profit, on Thursday confirmed fiscal 2025 forecast.

Determined by gel permeation chromatography (GPC) in THF. The oligomer formation was neglected. b M/C/B is the utilized number of ester groups (M) to base (B) and precatalyst (C) ratio. The reactions ...

The lowest uptake of the catalyst, when DVSi was used as the stabilizing ligand, was attributed to its low polarity or bulkiness. DVSi is two times heavier than NB and has a bidentate nature, which ...

Acute lung injury(ALI)/acute respiratory distress syndrome(ARDS) is a form of acute-onset hypoxemic respiratory failure characterised by an acute, diffuse ...

P2Rank: Protein-ligand binding site prediction from protein structure based on machine learning.